Align Technology Inc (ALGN)
244.34
-1.18
(-0.48%)
USD |
NASDAQ |
Jun 18, 09:38
Align Technology Research and Development Expense (Annual): 346.83M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 346.83M |
| December 31, 2022 | 305.26M |
| December 31, 2021 | 250.32M |
| December 31, 2020 | 175.31M |
| December 31, 2019 | 157.36M |
| December 31, 2018 | 128.90M |
| December 31, 2017 | 97.56M |
| December 31, 2016 | 75.72M |
| December 31, 2015 | 61.24M |
| December 31, 2014 | 52.80M |
| December 31, 2013 | 44.08M |
| December 31, 2012 | 42.87M |
| December 31, 2011 | 37.15M |
| Date | Value |
|---|---|
| December 31, 2010 | 26.00M |
| December 31, 2009 | 22.25M |
| December 31, 2008 | 26.16M |
| December 31, 2007 | 25.73M |
| December 31, 2006 | 18.47M |
| December 31, 2005 | 18.58M |
| December 31, 2004 | 15.76M |
| December 31, 2003 | 13.11M |
| December 31, 2002 | 13.06M |
| December 31, 2001 | 15.64M |
| December 31, 2000 | 9.169M |
| December 31, 1999 | 4.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
157.36M
Minimum
2019
346.83M
Maximum
2023
247.01M
Average
250.32M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| ResMed Inc | 287.64M |
| Stryker Corp | 1.388B |
| Edwards Lifesciences Corp | 1.072B |
| Zimmer Biomet Holdings Inc | 458.70M |